Breaking News: LRMR – Market Insights, Analysis & Latest Updates

LRMR

Larimar stock falls on adverse events despite positive data

Larimar Therapeutics shares dropped significantly after serious adverse events in a study, although analysts remain optimistic about its treatment prospects and upcoming milestones.

investing.com • 16/12/2024 - 20:44 PM

LRMR

Larimar Therapeutics stock plunges on clinical study concerns

Larimar Therapeutics shares dropped 30% after two patients had serious adverse events in a trial for Friedreich's ataxia treatment, though injections were generally well tolerated.

investing.com • 16/12/2024 - 16:01 PM

Greed and Fear Index

Note: The data is for reference only.

Greed

Larimar stock falls on adverse events despite positive data

Larimar Therapeutics stock plunges on clinical study concerns

Currency